Alterations in reference vessel diameter following intracoronary stent implantation: Important consequences for restenosis based on percent diameter stenosis
- 1 June 1995
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Diagnosis
- Vol. 35 (2) , 103-109
- https://doi.org/10.1002/ccd.1810350205
Abstract
The scaffolding effect of stent implantation has the potential to alter vascular geometry and dimensions. The objective of this study was to determine the impact of intracoronary stent implantation on the reference vessel diameter and the consequences of this on the frequency of restenosis applying the binary definitions of restenosis based on percent diameter stenosis. Routine angiographic follow‐up was performed in 79/80 consecutive patients who had a single elective Palmaz‐Schatz stent implanted in denovo lesions in native coronary arteries 6.5±3.4 mo after the index procedure. Complete quantitative angiographic follow‐up was available in 78 (98%). The mean reference vessel diameter was 2.9±0.6 mm preprocedure, increased to 3.1±0.5 mm immediately poststent implantation and was 2.6±0.6 mm at follow‐up (F = 6.45, P = 0.0001, ANOVA for repeated measures). In view of the varying reference vessel diameter, percent diameter stenosis postangioplasty and at follow‐up was determined by two methods: (1) automatically by the quantitative coronary angiographic analysis system and (2) by expressing the minimal luminal diameter postangioplasty and at follow‐up as a function of the original preprocedural reference vessel diameter. The restenosis rate was significantly greater for all definitions of restenosis when the minimal luminal diameter was determined as a function of the original preprocedure reference vessel diameter (e.g., 34% vs. 18% for the ⩾50% criterion, P = 0.018). Stent implantation results in alterations in reference vessel diameter, which have important consequences for the frequency of restenosis presented as a binary variable based on percent diameter stenosis.Keywords
This publication has 30 references indexed in Scilit:
- Evaluation of ketanserin in the prevention of restenosis after percutaneous transluminal coronary angioplasty. A multicenter randomized double-blind placebo-controlled trial.Circulation, 1993
- Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.Circulation, 1992
- Double-blind, randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty.Circulation, 1992
- Restenosis after coronary angioplasty: A multilvariate statistical model to relate lesion and procedure variables to restenosisJournal of the American College of Cardiology, 1991
- Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group.Circulation, 1990
- Myocardial protection during coronary angioplasty with an autoperfusion balloon catheter in humans.Circulation, 1988
- Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months.Circulation, 1988
- Restenosis after successful coronary angioplasty in patients with single-vessel disease.Circulation, 1986
- Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms.Circulation, 1985
- Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study.Circulation, 1984